MTB:NYSEM&T Bank Corporation Analysis
Data as of 2026-06-12 - not real-time
$227.82
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
M&T Bank (MTB) is trading at $227.82, just below its calculated resistance of $228.40 and comfortably above its 20‑day SMA of $215.35, indicating short‑term strength. The stock’s RSI of 66.7 suggests momentum is high but not yet overbought, while a bullish MACD (line $3.33 above signal $1.81) reinforces the upward bias. Valuation metrics show a trailing P/E of 12.8 versus the industry average of 16.6, a forward P/E of 10.9, and a price‑to‑book of 1.31, positioning MTB as fairly priced with modest upside of about 2.3% to the DCF fair value of $250. Operating margins are robust at 38.9% and profit margins at 31.5%, supported by 5.7% revenue growth YoY and a solid ROE of 10.3%. The balance sheet is net‑cash positive, with $16.7 B in cash offsetting $19.5 B of debt, and the dividend yield of 2.63% is backed by a payout ratio of 32.8%, indicating sustainability. Recent Q1 2026 earnings reported net income of $664 M and EPS of $4.13, beating expectations and underscoring earnings consistency. However, insider selling noted in recent headlines adds a note of caution for short‑term traders.
Looking ahead, the moderate beta of ~0.78 and a 30‑day volatility of 22% signal a balanced risk profile, while the “Extreme Greed” sentiment on the fear‑greed index reflects strong market appetite. The consensus “hold” rating with target prices near $230‑$233 aligns with the modest upside, and the dividend’s sustainability makes MTB attractive for income‑focused investors. Overall, the blend of solid fundamentals, fair valuation, and a stable dividend supports a buy recommendation for medium to long horizons, with a watchful hold stance in the near term.
Looking ahead, the moderate beta of ~0.78 and a 30‑day volatility of 22% signal a balanced risk profile, while the “Extreme Greed” sentiment on the fear‑greed index reflects strong market appetite. The consensus “hold” rating with target prices near $230‑$233 aligns with the modest upside, and the dividend’s sustainability makes MTB attractive for income‑focused investors. Overall, the blend of solid fundamentals, fair valuation, and a stable dividend supports a buy recommendation for medium to long horizons, with a watchful hold stance in the near term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Price near resistance with bullish MACD
- High RSI indicating potential pull‑back risk
- Increasing volume supporting current trend
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Fair valuation with modest upside to analyst targets
- Strong operating margins and earnings growth
- Sustainable dividend yield attractive for income investors
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Net‑cash position and low leverage
- Consistent profitability and solid ROE
- Stable dividend and defensive regional‑bank business model
Key Metrics & Analysis
Financial Health
Revenue Growth5.70%
Profit Margin31.48%
P/E Ratio12.8
ROE10.29%
ROA1.38%
P/B Ratio1.3
Op. Cash Flow$3.4B
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI66.7
Support$202.85
Resistance$228.40
MA 20$215.35
MA 50$215.53
MA 200$205.59
MACDBullish
VolumeIncreasing
Fear & Greed Index86.71
Valuation
Fair Value$250.00
Target Price$233.17
Upside/Downside2.35%
GradeFair
TypeBlend
Dividend Yield2.63%
Risk Assessment
Beta0.78
Volatility22.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.